Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P709: Is there a difference in adalimumab drug levels according to pen vs. syringe use: An international, multi-centre retrospective analysisECCO '18 Vienna
Year: 2018
Authors:

R. Little1*, I. Chu1, E. van der Zanden2, E. Flanagan3, S. Bell3, M. Sparrow1, E. Shelton4, S. Connor2, X. Roblin5, M. Ward1

1Alfred Health and Monash University, Gastroenterology, Melbourne, Australia, 2Liverpool Hospital and University of New South Wales, Gastroenterology, Sydney, Australia, 3St. Vincent's Hospital and University of Melbourne, Gastroenterology, Melbourne, Australia, 4Monash Health and Monash University, Gastroenterology, Mebourne, Australia, 5CHU Saint-Etienne, Gastro-entérologie et Hépatologie, Saint-Etienne, France

P710: Efficacy of therapeutic intervention for ulcerative colitis patients with the Mayo Endoscopic Score of 1ECCO '18 Vienna
Year: 2018
Authors:

T. Fukuda1*, M. Naganuma1, S. Sugimoto1, K. Ono1, K. Nanki1, S. Mizuno1, K. Kimura2, M. Mutaguchi1, K. Takabayashi2, N. Inoue3, H. Ogata2, Y. Iwao3, T. Kanai1

1Keio University School of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokyo, Japan, 2Keio University School of Medicine, Center for Diagnostic and Therapeutic Endoscopy, Tokyo, Japan, 3Keio University School of Medicine, Center for Preventive Medicine, Tokyo, Japan

P711: A pilot study using point of care testing for infliximab and faecal calprotectin in IBD patients with a secondary loss of responseECCO '18 Vienna
Year: 2018
Authors:

S. Restellini1,2*, T. Bessissow1, C. Lemieux1, C.-Y. Chao1,3, G. Wild1, E. Seidman1, A. Bitton1, P.L. Lakatos1,4, W. Afif1

1McGill University Health Centre, Gastroenterology, Montreal, Canada, 2Division of Gastroenterology and Hepatology, Department of Medical Specialties, Geneva, Switzerland, 3Princess Alexandra Hospital, Department of Gastroenterology and Hepatology, Brisbane, Australia, 4Semmelweis University, 1st Department of Medicine, Budapest, Hungary

P712: Establishing pharmacokinetic equivalence between adalimumab and ABP 501 in the presence of anti-drug antibodies using population PK modellingECCO '18 Vienna
Year: 2018
Authors:

S. Doshi*, E. Krishnan, H. Wang, N. Zhang, V. Chow

Amgen Inc., Biosimilars, Thousand Oaks, USA

P713: Home-based vedolizumab infusions: A suitable alternative to routine hospital infusionsECCO '18 Vienna
Year: 2018
Authors:

N. Peek-Kuijt1*, J. Nieuwstraten1, L. van Ginkel2, J. Maljaars1, A. van der Meulen- de Jong1

1Leiden University Medical Center, Gastroenterology, Leiden, The Netherlands, 2Leiden University Medical Center (LUMC), Care Registration, Leiden, The Netherlands

P714: Vedolizumab, an adequate option in medically refractory and thiopurine-intolerant inflammatory bowel disease patientsECCO '18 Vienna
Year: 2018
Authors:

M. Iborra1*, N. Maroto2, P. Navarro-Cortes3, B. Beltran1, M. Boscá-Watts3, I. Ferrer2, N. Garcia-Morales1, E. Sáez-González1, J. Hinojosa2, M. Minguez3, P. Nos1

1La Fe University and Polytechnic Hospital and CIBER-EHD, Department of Gastroenterology, Valencia, Spain, 2Hospital de Manises, Department of Gastroenterology, Manises, Spain, 3University Clinic Hospital of Valencia, Department of Gastroenterology and Hepatology, Valencia, Spain

P715: Opioid use in patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

X. Lin, J. Lofland, L. Zhang, K. Lee, S. Sloan*, L. Chamaa, C. Marano, S. Plevy

Janssen Research and Development, LLC, Spring House, USA

P716: Current smoking trends in British IBD patients in the age of e-cigarettesECCO '18 Vienna
Year: 2018
Authors:

K. Loonat, R. Sagar, C. Selinger*

St James University Hospital, Gastroenterology, Leeds, UK

P717: Comparison of two different techniques to assess vedolizumab trough levels in adult patients with IBDECCO '18 Vienna
Year: 2018
Authors:

C. Berger1*, C. Christ1, F.-P. Armbruster1, H. Schulze2, A. Dignass2,3, J. Stein3,4, K. Farrag3,4

1Immundiagnostik AG, Bensheim, Germany, 2Agaplesion Markus Krankenhaus, Department of Gastroenterology, Frankfurt/Main, Germany, 3Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 4DGD Clinics Sachsenhausen, Frankfurt/Main, Germany

P718: Discrepancies between patients’ preferences and physicians’ preference perception for oral formulations: A real-life surveyECCO '18 Vienna
Year: 2018
Authors:

P. Marchi1*, S. Timeus1, L. Mackenzie-Smith1, P. Le Calvé2, R. Young2

1Tillotts Pharma AG, Rheinfelden, Switzerland, 2Kantar Health, Paris, France

P719: Does radiation to the pelvis portend worse ileal pouch outcomes? An international multi-institution collaborative studyECCO '18 Vienna
Year: 2018
Authors:

A. Lightner1*, A. Spinelli2, N. McKenna1, J. Warusavitarne3, P. Fleshner4

1Mayo Clinic, Colon and Rectal Surgery, Rochester, USA, 2Humanitas Clinical Institute, Colon and Rectal Surgery, Milan, Italy, 3St Marks Hospital, Colon and Rectal Surgery, London, UK, 4Cedars-Sinai Los Angeles, Colon and Rectal Surgery, Los Angeles, USA

P720: Is there a difference in trough levels and immunogenicity between Crohn’s disease and ulcerative colitis patients treated with infliximab?ECCO '18 Vienna
Year: 2018
Authors:

D. Perdigoto, C. Macedo*, F. Portela, S. Lopes, M. Ferreira, M. Ferreira, S. Mendes, L. Tomé

Coimbra Hospital and University Center, Gastroenterology, Coimbra, Portugal

P721: Psychological care is needed and welcomed by patients with inflammatory bowel disease under routine careECCO '18 Vienna
Year: 2018
Authors:

T. Lores1*, C. Goess1, C. Hrycek2, R. Grafton1, J. Hughes1, L. Cronin1, A.L. Burke3, K.L. Collins3, A. Chur-Hansen4, A. Mikocka-Walus5, J.M. Andrews1

1Royal Adelaide Hospital, Department of Gastroenterology, Adelaide, Australia, 2Royal Adelaide Hospital, Department of General Medicine, Adelaide, Australia, 3Royal Adelaide Hospital, Department of Psychology, Adelaide, Australia, 4University of Adelaide, Adelaide, Australia, 5Deakin University, Melbourne, Australia

P722: Trough levels, drug switching and antidrug antibody loss: Analysis of real-life infliximab and adalimumab data in IBDECCO '18 Vienna
Year: 2018
Authors:

D. Ho1, T. Sipponen1,2*, T.S. Jokiranta1,3

1University of Helsinki, Helsinki, Finland, 2Helsinki University Hospital, Gastroenterology, Helsinki, Finland, 3United Medix Laboratories, Helsinki, Finland

P723: Effectiveness and persistence of vedolizumab in patients with Inflammatory bowel Disease: Results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)ECCO '18 Vienna
Year: 2018
Authors:

C. Reenaers1*, A. Cremer2, O. Dewit3, B. de Vroey4, W. Van Moerkercke5, P. Bossuyt6, V. Muls7, J. Imschoot8, S. Block8, A. Hantson8, P. Van Hootegem9

1CHU Liège, Gastroenterology, Liège, Belgium, 2ULB Erasme, Brussels, Belgium, 3UCL, Brussels, Belgium, 44Centre Hospitalier Jolimont, Haine-Saint-Paul, Belgium, 5Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium, 6Imelda GI Clinical Research Centre, Keerbergen, Belgium, 7Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium, 8Takeda Belgium, Brussels, Belgium, 9Algemeen Ziekenhuis Sint-Lucas Brugge vzw, Brugge, Belgium

P724: Unchanged infliximab serum concentrations after switching from the originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease: Results from a prospective study (SECURE)ECCO '18 Vienna
Year: 2018
Authors:

A. Strik1*, W. van de Vrie2, J. Bloemsaat-Minekus3, M. Nurmohamed4, P. Bossuyt5, A. Bodelier6, T. Rispens7, Y. van Megen3, G. D'Haens1

1Academic Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 2Albert Schweitzer Hospital, Department of Gastroenterology and Hepatology, Dordrecht, The Netherlands, 3Mundipharma Pharmaceuticals BV, Hoevelaken, The Netherlands, 4Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands, 5Imelda hospital, Bonheiden, Belgium, 6Amphia Hospital Breda Loc. Langendijk, Breda, The Netherlands, 7Academic Medical Center (AMC), Tytgat Institute for Intestinal and Liver Research, Amsterdam, The Netherlands

P725: Ileal pouch excision: A contemporary observational cohortECCO '18 Vienna
Year: 2018
Authors:

G. Worley1,2*, D. Patsouras3, K. Sahnan1,3, S. Adegbola1,3, H. Mahmood3, O. Faiz1,3, S. Clark1,3

1Imperial College London, Department of Surgery and Cancer, London, UK, 2St Mark's Hospital and Academic Institute, Surgical Epidemiology Trials and Outcome Centre, London, UK, 3St Mark's Hospital and Academic Institute, London, UK

P726: Metalloproteinase 3: A new marker for assessing loss of response to infliximab in IBDECCO '18 Vienna
Year: 2018
Authors:

B. Barberio1*, R. D'Incà2, M. Dalla Gasperina1, S. Facchin1, L. Digiglio1, R. Cardin1, G. Lorenzon1, A. Rigo1, G.C. Sturniolo1

1University of Padua, Gastroenterology, Padova, Italy, 2University of Padua, Gastroenterologia, Padova, Italy

P727: Efficacy of vedolizumab (VDZ) by disease localisation in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

M. Allez1*, F. Braegger2, C. Kempf2, P. Michetti3

1Hôpital Saint-Louis, APHP, INSERM UMRS 1160, Université Denis Diderot, Gastroenterology and Hepatology, Paris, France, 2Takeda Pharmaceuticals International AG, Zurich, Switzerland, 3Gastro-entérologie La Source-Beaulieu and Division of Gastroenterology, Centre Hospitalier Universitaire Vaudois, Crohn’s and Colitis Center, Lausanne, Switzerland

P728: Efficacy of anti-TNF treatment in patients with refractory ulcerative proctitis: Results from a French retrospective multi-centre national cohortECCO '18 Vienna
Year: 2018
Authors:

G. Pineton de Chambrun1*, A. Amiot2, G. Bouguen3, S. Viennot4, R. Altwegg1, E. Louis5, M. Collins6, M. Fumery7, F. Poullenot8, L. Armengol9, A. Buisson10, V. Abitbol11, Y. Bouhnik12, D. Laharie8, P. Seksik13, S. Nancey14, P. Blanc1, M. Nachury15, L. Peyrin-Biroulet16

1Montpellier University Hospital, Gastroenterology, Montpellier, France, 2Henri-Mondor University Hospital, Gastroenterology, Creteil, France, 3Rennes University Hospital, Gastroenterology, Rennes, France, 4Caen University Hospital, Gastroenterology, Caen, France, 5Liège University Hospital, Gastroenterology, Liège, Belgium, 6APHP Paris Sud University , Gastroenterology, Le Kremlin Bicêtre, France, 7Amiens University Hospital, Gastroenterology, Amiens, France, 8Bordeaux University Hospital, Gastroenterology, Bordeaux, France, 9Rouen University Hospital, Gastroenterology, Rouen, France, 10Clermont-Ferrand University Hospital, Gastroenterology, Clermont-Ferrand, France, 11Cochin University Hospital, Gastroenterology, Paris, France, 12Beaujon University Hospital, Gastroenterology, Paris, France, 13Saint-Antoine University Hospital, Gastroenterology, Paris, France, 14Lyon University Hospital, Gastroenterology, Lyon, France, 15Lille University Hospital, Gastroenterology, Lille, France, 16Nancy University Hospital, Gastroenterology, Nancy, France